Positivity Rate of [18F]Fluciclovine PET/CT in Patients with Suspected Prostate Cancer Recurrence at PSA Levels Below 1 ng/mL

…, P Lovrec, AA Solanki, MS Gabriel… - Molecular Imaging and …, 2022 - Springer
Purpose Early and precise localization of recurrent prostate cancer lesions after local
therapy facilitates optimal disease management. Here, we present results from a single-center …

Characterizing and Mitigating Bladder Radioactivity on 18F-Fluciclovine PET/CT

…, DM Schuster, RH Wagner, M Gabriel… - Journal of Nuclear …, 2020 - Soc Nuclear Med
18 F-fluciclovine PET is approved for prostate cancer recurrence imaging. According to the
radiopharmaceutical package insert, only 3% of the tracer is expected to be excreted in the …

99mTc-MAA SPECT/CT imaging for quantitative assessment of lung shunt fraction prior to 90Y transarterial radioembolization

H GIll, J Bian, M Gabriel, C Molvar, R Wagner… - 2019 - Soc Nuclear Med
265 Objectives: Selective Internal Radiation Therapy (SIRT) is a widely used radioembolization
procedure performed on patients with unresectable primary or metastatic hepatic …

[HTML][HTML] A multimodal and pathological analysis of a renal cell carcinoma metastasis to the thyroid gland 11 years post nephrectomy

TR Geisbush, Z Dymon, MS Gabriel… - Journal of Radiology …, 2019 - ncbi.nlm.nih.gov
Thyroid lesions have a comprehensive differential diagnosis which include benign and
malignant entities, such as metastases. However, metastases only account for a small …

Genitourinary system

MS Gabriel, B Savir-Baruch, RH Wagner… - … Nuclear Medicine MCQs …, 2021 - Springer
A 67-year-old female patient is referred for a renogram evaluation due to the CT findings
shown in Fig. 1 and subsequent PET/CT findings shown in Fig. 2.

Effect of hormonal therapy on 18F-fluciclovine PET/CT in the detection of prostate cancer recurrence, localization of metastatic disease, and correlation with prostate …

…, D Grybowski, C Joyce, E Rashad, MS Gabriel… - … Oncology: Seminars and …, 2022 - Elsevier
Introduction 18 F-Fluciclovine, is a positron emission tomography (PET) radiotracer approved
for the localization of sites of prostate cancer recurrence in men with a rising prostate-…

Proof of concept: design and initial evaluation of a device to measure gastrointestinal transit time

…, JR Halama, M Venu, MS Gabriel… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Chronic constipation and gastrointestinal motility disorders constitute a large part of a
gastroenterology practice and have a significant impact on a patient's quality of life and lifestyle. In …

Factors influencing the positivity rate of commercial 18F-Fluciclovine imaging in men with suspected recurrent prostate cancer

…, GN Gupta, W Adams, R Wagner, M Gabriel… - 2018 - Soc Nuclear Med
1470 Objectives: To evaluate the factors influencing the positivity rate of commercial 18 F-fluciclovine
positron emission tomography/computed tomography (PET/CT) in clinical practice. …

Managing Written Directives: A Software Solution to Streamline Workflow

RH Wagner, B Savir-Baruch, MS Gabriel… - Journal of nuclear …, 2017 - Soc Nuclear Med
A written directive is required by the US Nuclear Regulatory Commission for any use of 131
I above 1.11 MBq (30 μCi) and for patients receiving radiopharmaceutical therapy. This …

Endocrine System

MS Gabriel, B Savir-Baruch, RH Wagner… - … Nuclear Medicine MCQs …, 2021 - Springer
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)—Thyroid Carcinoma,
Version 2.2017—May 17, 2017—Available at NCCN. org.